Edaravone and Dexborneol Sublingual Tablet for Treating Chemotherapy- Induced Cognitive Impairment Study

NCT07454473 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Chemo Brain

Interventions

DRUG: Edaravone Dexborneol

Sponsor

Chuansheng Zhao